Publication:
US market entry by Spanish pharmaceutical firms

dc.affiliation.dptoUC3M. Departamento de Economía de la Empresaes
dc.contributor.authorGiarratana, Marco S.
dc.contributor.authorMartínez-Ros, Ester
dc.contributor.authorCesaroni, Fabrizio
dc.contributor.editorUniversidad Carlos III de Madrid. Departamento de Economía de la Empresa
dc.date.accessioned2010-03-15T12:01:55Z
dc.date.available2010-03-15T12:01:55Z
dc.date.issued2010-02
dc.description.abstractThis work explores the factors that spur firms’ propensity to enter in international markets. Among the whole population of Spanish firms active in the pharmaceutical sector (over the period 1995-2004), we identify those firms that have entered the US market by assessing whether they have filed at least a trademark in the US Patents and Trademarks Office. By means of a hazard model, we empirically estimate which firm’s characteristics affect the probability of entry in the US market in a given year. Results show that technological capabilities (breadth and depth of firms’ patent base), and the firm’s cost structure explain the entry in the US market with a branded product. Moreover, our evidence shows that entry strategies based on differentiation advantage (technological diversification) and strategies based on cost advantage (scale economies) are exclusive and do not mix well each other
dc.format.mimetypeapplication/pdf
dc.identifier.repecwb101103
dc.identifier.urihttps://hdl.handle.net/10016/7094
dc.language.isoeng
dc.relation.ispartofseriesUC3M Working papers. Business Economics
dc.relation.ispartofseries10-03
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 España
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/
dc.subject.ecienciaEconomía
dc.subject.jelF23
dc.subject.otherForeign market entry
dc.subject.otherInternationalization strategies
dc.subject.otherFirm-Specific advantages
dc.subject.otherCompetitive advantage
dc.subject.otherInnovation and R&D
dc.subject.otherPatents
dc.subject.otherTrademarks
dc.titleUS market entry by Spanish pharmaceutical firms
dc.typeworking paper*
dspace.entity.typePublication
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
wb101103.pdf
Size:
350.9 KB
Format:
Adobe Portable Document Format
Description: